SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Human cytomegalovirus infections are still associated with severe morbidity and mortality in immunocompromised individuals, despite the availability of five drugs that are currently licensed for ...

Among adults hospitalized with influenza-associated pneumonia, delayed vs timely antiviral treatment initiation was associated with greater 30-day mortality risk. Delayed antiviral therapy initiation ...

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

In this study, utilization rates of antiviral therapy were 57% for patients with HBV-associated HCC and 35% for patients with HCV-associated HCC. Antiviral therapy initiated before or within 6 months ...

By a News Reporter-Staff News Editor at South Korea Daily Report-- Investigators discuss new findings in Herpesvirus Diseases ...

Please provide your email address to receive an email when new articles are posted on . Adjusted analysis demonstrated no association between nucleos(t)ide analogue retreatment and HBsAg seroclearance ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox, as well as ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Antiviral therapy reduced incidence of long COVID-19 ...

This Collection supports and amplifies research related to SDG3, SDG9 and SDG10. This collection highlights research and reviews in the development, optimization, and application of antiviral ...